DeraMAXX Chewable Tablet
DeraMAXX is an FDA-approved preparation containing DeraMAXX, for veterinary use. Available by prescription.
Veterinarians most commonly consider deracoxib for patients presented with orthopedic challenges, such as osteoarthritis or as part of a management approach following dental or orthopedic surgical procedures. The decision to select this specific NSAID is frequently a point of discussion when a veterinarian seeks to manage the inflammatory environment associated with chronic joint conditions or acute tissue recovery.
At a pharmacological level, deracoxib acts as a selective inhibitor of the cyclooxygenase-2 (COX-2) enzyme. This is a enzyme that plays a primary role in the production of prostaglandins—chemical messengers that signal inflammation and discomfort within the body. By managing the activity of COX-2, the medication provides a mechanism for addressing the underlying inflammatory process. Crucially, deracoxib is characterized by its high selectivity, meaning it has minimal influence on the cyclooxygenase-1 (COX-1) enzyme at clinical doses. COX-1 is a enzyme responsible for maintaining essential functions such as protecting the stomach lining and ensuring proper blood flow to the kidneys. Your veterinarian will determine the clinical appropriateness of deracoxib based on your pet’s physical examination, diagnostic history and baseline laboratory results.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
Commonly observed effects following the administration of deracoxib include localized digestive changes such as vomiting, diarrhea or a temporary decrease in appetite. Because medications in the NSAID class influence prostaglandin levels, your veterinarian will monitor for signs of gastric ulceration or significant shifts in renal and hepatic function. This monitoring is typically performed through periodic blood work and physical assessments. Owners should monitor their pet for any observational signs such as dark, tarry stools, increased thirst or yellowing of the skin and eyes (jaundice). If you notice any of these changes or if your pet exhibits unusual lethargy, contact your veterinarian promptly.
This medication is typically used with extra caution or avoided in patients with known pre-existing kidney, liver or gastrointestinal disease. It is also carefully evaluated in dogs that are presented with dehydration or low blood pressure. Significant interactions can occur if deracoxib is administered concurrently with other NSAIDs or corticosteroids like prednisone, as these combinations can influence the risk of digestive or renal complications. Your veterinarian is the right person to provide guidance on the necessary duration of use and the most appropriate monitoring schedule to ensure the management approach remains suitable for your pet's comfort and long-term recovery.
Yes. Deramaxx is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid prescription from a licensed veterinarian. Mixlab verifies authorization before any medication is prepared or shipped to your home.
Deramaxx is available as a commercial beef-flavored chewable tablet. When a veterinarian determines that a compounded formulation—such as an oral liquid or a different flavor profile—better suits an individual patient's needs, Mixlab's compounding team can prepare that formulation with a valid prescription. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians most commonly discuss deracoxib for the management of discomfort and inflammation associated with osteoarthritis or recovery from surgery. Its mechanism acts to manage specific enzymes involved in the inflammatory response, providing a method for supporting your pet’s mobility and comfort.
Veterinarians often recommend administering deracoxib with a meal or shortly after feeding to manage the risk of localized stomach upset. Giving the medication with food helps ensure it is well-tolerated by your pet’s digestive system during the management course.
Your veterinarian will typically recommend periodic blood work to monitor your pet's liver and kidney values while they are receiving this medication. This provides a method for ensuring the management approach remains safe and appropriate for your pet's specific health status.
